Valerie Daggett

UW researchers discover a link between bacterial infections and Alzheimer’s disease

UW Bioengineering's Valerie Daggett and other UW researchers discover a link between bacterial infections and Alzheimer's disease (AD)

2024-05-30T07:04:49-07:00May 14th, 2024|

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer’s disease, researchers show

Researchers led by UW Department of Bioengineering Professor Valerie Daggett have developed synthetic peptides that can target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. The team reports their achievement in a paper published the week of April 15 in the Proceedings of the National Academy of Sciences. 

2022-08-04T03:42:19-07:00April 16th, 2019|

Suzie Pun and Valerie Daggett elected AIMBE Fellows

UW Bioengineering Professors Suzie Pun and Valerie Daggett have been elected to the AIMBE College of Fellows Class of 2015. Drs. Pun and Daggett join UW Bioengineering's 18 other AIMBE Fellows. AIMBE, or the American Institute for Medical and Biological Engineering,is a non-profit advocacy organization dedicated to improving lives through medical and biological engineering.

2020-10-26T08:30:43-07:00January 26th, 2015|

Nobel Laureate Michael Levitt to present December 2014 UW Walker Ames Lecture

UW Bioengineering Professor Dr. Valerie Daggett is hosting December 2014's UW Walker Ames lecturer, Dr. Michael Levitt, the Robert W. Vivian K. Cahill Professor of Cancer Research in the Department of Structural Biology at Stanford School of Medicine. Dr. Levitt is a 2013 Nobel Laureate in Chemistry and was also Dr. Daggett's postdoc advisor in the early 1990s.

2021-01-21T06:04:34-08:00November 21st, 2014|

Valerie Daggett’s research featured in Alaska Airlines magazine

UW Bioengineering Professor Dr. Valerie Daggett's research was featured in an article, "Innovative Medicine", published in the November 2014 issue of Alaska Airlines Magazine. The article discussed novel approaches to treating complex diseases currently being developed by Seattle-area researchers, and details Dr. Daggett's work designing peptides to neutralize harmful changes to proteins thought to have a role in amyloid diseases like Alzheimer's.

2020-10-26T08:31:22-07:00November 13th, 2014|
Go to Top